Delivery Order SPE2DR25D6029-SPE2DR26FXR7D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,258.24 to AmerisourceBergen Drug Corp for the supply of Brimonidine Tartrate 0.15% ophthalmic drops (5mL) on January 27, 2026, with completion scheduled for January 28, 2026. This award was not designated as a set-aside contract and utilized firm fixed-price pricing. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on December 22, 2025, with a contract ceiling value of $1,115.28 and an ultimate completion date of December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $3,193.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Brimonidine Tartrate 0.15% Ophthalmic Drops, 10 mL, with a ceiling value of $1,091.13. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Brimonidine Tartrate 0.15% ophthalmic drops, valued at $1,213.60, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger indefinite delivery contract (IDC) vehicle that...
- The Defense Logistics Agency awarded a $1,960.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.1% ophthalmic drops (5mL) with an ultimate completion date of July 31, 2025. This delivery order, issued on July 30, 2025, is classified as a child contract and was awarded without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brimonidine...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,745.53 firm fixed-price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% eye drops in 10 mL bottles. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,439.96 firm fixed-price contract is for the supply of 4566932081 - Brimonidine Tartrate 0.15% Ophthalmic Drops, 10 mL. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 delivery order contract is for the supply of brimonidine tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price (FFP) delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,956,051 units of Brimonidine Tartrate 0.15% eye drop solution in 10 mL bottles. The $1,557.50 contract has a performance period through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor, providing pharmaceutical and medical supply distribution services to the Department of...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXR7DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,196.64 to AmerisourceBergen Drug Corp for the supply of Brimonidine Tartrate 0.15% ophthalmic drops (10 mL) on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award is a child contract under the parent organization Cencora, Inc., which conducts business as AmerisourceBergen. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, generic and brand-name drugs, vaccines, and related medical commodities. The Defense Logistics Agency utilizes such contracts to ensure reliable access to critical pharmaceutical products across the military health system and other federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/27/26 |